Sleep Apnea Stocks
Medical device manufacturers, specialty pharmaceutical firms, and durable medical equipment providers address the respiratory and neurological complications associated with sleep-disordered breathing.
As of Oct 23, 2026, Sleep Apnea has 12 US-listed companies worth $53.6B combined. The median member moved +1.0% over the past week; APMD led at +6.9% and NYXH trailed at -24.8%.
Companies in Sleep Apnea
- RMD – ResMed Inc, $35.6B
- AXSM – Axsome Therapeutics Inc, $7.6B
- LIVN – LivaNova PLC, $4.3B
- HRMY – Harmony Biosciences Holdings, $2.1B
- INSP – Inspire Medical Systems Inc, $2B
- APMD – Apnimed, Inc. Common Stock, $771M
- AHCO – Adapthealth Corp, $770M
- VMD – Viemed Healthcare Inc, $355M
- NYXH – Nyxoah, $121M
- IXHL – Incannex Healthcare Inc., $40.3M
- ACH – Accendra Health Inc, $19.6M
- VVOS – Vivos Therapeutics Inc, $4.5M